In compliance with Regulation 30 of the SEBI (LODR) Regulations, Sanofi India has submitted the disclosure regarding Order issued by the Commissioner Central GST & Central Excise, Vadodara II. The matter was remanded by CESTAT to the commissioner for examination regarding the reversal of CENVAT credit. Following the remand, the commissioner confirmed the demand of Rs. 5,25,70,852 along with an equivalent penalty. While the matter was reconsidered, the commissioner proceeded to confirm the demand and penalty as stated.
The above information is a part of company’s filings submitted to BSE.
